Tuesday, May 29, 2012

Senators Want Antipsychotic Drug Use Better Controlled in Nursing Homes

Senators from both parties joined with the Chairman of the Senate Special Committee on Aging, Sen. Herb Kohl, D-Wis., to propose legislation to combat the costly and inappropriate – yet widespread – use of antipsychotic drugs in nursing homes.

Joining with Sen. Kohl, Sen. Chuck Grassley, R-Iowa, and Richard Blumenthal, D-Conn., offered the amendment to S. 3187, the Food and Drug Administration Safety and Innovation Act.

It will require the Health and Human Services Secretary to issue standardized protocols for obtaining informed consent, or authorization from patients or their designated health care agents or legal representatives, acknowledging possible risks and side effects associated with the antipsychotic, as well as alternative treatment options, before administering the drug for off-label use.

“The overuse of antipsychotics is a common and well-recognized problem that puts frail elders at risk and costs taxpayers hundreds of millions of dollars each year,” Kohl said.

“We need a new policy that helps to ensure that these drugs are being appropriately used to treat people with mental illnesses, not used to curb behavioral symptoms of Alzheimer’s or other dementias.”

Full Article and Source:
Senators Want Antipsychotic Drug Use Better Controlled in Nursing Homes


Daniel Haszard said...

A patient speaks:
There are two kinds of antipsychotics the 50 year old tried and tested inexpensive *typical* antipsychotics like Thorazine,and the newer so-called *atypicals* like Risperdal,Seroquel,Zyprexa.
These drugs are lifesavers for those with delusional mental illness which is only 1 percent of the population.
The saga of the so called *atypical antipsychotics* is one of incredible profit.Eli Lilly made $65 BILLION on Zyprexa franchise (*Viva Zyprexa* Lilly sales rep slogan).

Described as *the most successful drug in the history of neuroscience* the drugs at $12 pill are used by states to medicate deinstitutionalized mental patients to keep them out of the $500-$1,200 day hospitals.There is a whole underclass block of our society,including children in foster care that are the market for these drugs,but have little voice of protest if harmed by them.I am an exception,I got diabetes from Zyprexa as an off-label treatment for PTSD and I am not a mentally challenged victim so I post.

Google-Haszard Zyprexa
--Daniel Haszard

Thelma said...

And I thought Thorazine was bad when I found my father restrained and on Thorazine almost 35 years ago.

StandUp said...

I appreciate your comment, Mr. Haszard. Psychotropics have their place, but that place is not to chemically restrain elderly or disabled people.

I believe this article is just PR work, however. How long has the Senate Special Committee on Aging known the problem and yet done nothing?

Anonymous said...

I hadn't thought of it, but I think you're right, StandUp. We see lots of hearings on C-span, but that's basically all we see. Where's the action?